Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Japan is looking to other countries in its efforts to arrest the alarming decline in its high-quality scientific research. The strategy of funding selected institutions to boost their overseas collaboration is starting to bear fruit. The proportion of articles co-authored with international researchers has increased, but correcting the slide in overall output is proving difficult.
Tokyo University of Pharmacy and Life Sciences is a hub for Japanese drug discovery, particularly for rare diseases overlooked by the pharmaceutical industry.
Janssen Japan is looking to Japan’s rich academic knowledge base, and investing in long-term drug development partnerships, as the face of R&D changes.
From robotic exoskeletons to sleep disorder technology, the University of Tsukuba is at the forefront of private enterprise partnerships to produce successful start-ups.